Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alibaba Hong Kong Entrepreneurs Fund, commonly operating under the broader Alibaba Entrepreneurs Fund brand, is a not-for-profit startup investment initiative launched by Alibaba Group in 2015. It focuses on supporting Hong Kong-based entrepreneurs and young people through venture-style investment, strategic guidance, ecosystem programs, and access to Alibaba's commercial and technology networks. The organization is not a drug developer, biotech company, or healthcare operating company; rather, it is an investor and startup ecosystem builder with exposure across multiple sectors, including occasional health-tech investments. Its activities include direct startup investment, entrepreneurship programs, and community-building initiatives in Hong Kong and the Greater Bay Area. For a biotech analyst, the key point is that this entity is best understood as an investor in innovation companies rather than a life sciences operating business with its own therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alibaba Entrepreneurs Fund.